Their stories are presented alongside the broader effort behind the Texas Ibogaine Initiative, which seeks to fund clinical trials evaluating ibogaine’s potential as a treatment for addiction and related mental health conditions. Advocates argue that expanding scientific research could help determine whether the compound may eventually become an approved therapeutic option within the U.S. healthcare system.
Videos
ACS Media - Ibogaine Helps Heal US Veterans Chase Rowan and Marcus Luttrell
January 15, 2025
In this video, Texas veterans Chase Rowan and Marcus Luttrell share personal accounts of their struggles with opioid use and the lasting physical and psychological effects of military service. Both describe traveling to Mexico to receive ibogaine treatment, as the compound remains classified as a Schedule I substance in the United States and is not available domestically as a medical therapy.